The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $24.28

Today's change-0.06 -0.25%
Updated July 29 4:01 PM EDT. Delayed by at least 15 minutes.
 

Boston Scientific Corp

NYSE: BSX
Last

(U.S.) $24.28

Today's change-0.06 -0.25%
Updated July 29 4:01 PM EDT. Delayed by at least 15 minutes.

Boston Scientific Corp down (U.S.)$0.06

Boston Scientific Corp closed lower Friday, dropping (U.S.)$0.06 or 0.25% to (U.S.)$24.28. Over the last five days, shares have gained 1.51% and are currently 2.06% off of the 52-week high. Shares have outperformed the S&P 500 by 37.10% during the last year.

Key company metrics

  • Open(U.S.) $24.33
  • Previous close(U.S.) $24.34
  • High(U.S.) $24.56
  • Low(U.S.) $23.98
  • Bid / Ask(U.S.) $23.73 / (U.S.) $24.29
  • YTD % change+31.67%
  • Volume12,999,857
  • Average volume (10-day)9,739,487
  • Average volume (1-month)11,797,599
  • Average volume (3-month)10,766,851
  • 52-week range(U.S.) $14.18 to (U.S.) $24.79
  • Beta1.00
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward22.25×
  • Forward PEG1.72×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.03
Updated July 29 4:01 PM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1,9641,9781,8881,843
Total other revenue--------
Total revenue1,9641,9781,8881,843
Gross profit1,3961,4161,3541,311
Total cost of revenue568562534532
Total operating expense1,6712,2492,1871,624
Selling / general / administrative711774720696
Research & development210244221220
Depreciation / amortization136134131116
Interest expense (income), net operating--------
Unusual expense (income)2751856442
Other operating expenses, total19171718
Operating income293-271-299219
Interest income (expense), net non-operating-59-59-58-106
Gain (loss) on sale of assets--------
Other--------
Income before tax228-338-367105
Income after tax202-142-198102
Income tax, total26-196-1693
Net income202-142-198102
Total adjustments to net income--------
Net income before extra. items202-142-198102
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items202-142-198102
Inc. avail. to common incl. extra. items202-142-198102
Diluted net income202-142-198102
Dilution adjustment--------
Diluted weighted average shares1,3701,3461,3441,362
Diluted EPS excluding extraordinary itemsvalue per share0.15-0.11-0.150.07
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.160.140.130.10